Letter to the Editor on: A. Siegmann et al. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival. Results of a retrospective study. In: Strahlenther Onkol 2011;187:467-72 (No. 8) (DOI 10.1007/s00066-011-2229-3). P. Ghadjar, D. Zwahlen, D.M. Aebersold: Selection bias is not a good reason for dose intensification in patients with PSA recurrence after radical prostatectomy

Ghadjar, Pirus (2011). Letter to the Editor on: A. Siegmann et al. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival. Results of a retrospective study. In: Strahlenther Onkol 2011;187:467-72 (No. 8) (DOI 10.1007/s00066-011-2229-3). P. Ghadjar, D. Zwahlen, D.M. Aebersold: Selection bias is not a good reason for dose intensification in patients with PSA recurrence after radical prostatectomy. Strahlentherapie und Onkologie, 187(11), 763; author reply 764. Heidelberg: Urban and Vogel 10.1007/s00066-011-9229-1

[img]
Preview
Text
66_2011_Article_9229.pdf - Published Version
Available under License Publisher holds Copyright.

Download (95kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Ghadjar, Pirus

ISSN:

0179-7158

Publisher:

Urban and Vogel

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:19

Last Modified:

30 Nov 2019 19:51

Publisher DOI:

10.1007/s00066-011-9229-1

PubMed ID:

22037657

Web of Science ID:

000296533000009

BORIS DOI:

10.7892/boris.6258

URI:

https://boris.unibe.ch/id/eprint/6258 (FactScience: 211168)

Actions (login required)

Edit item Edit item
Provide Feedback